Cargando…
A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling
An optimal intranasal (IN) dose of human mesenchymal stem cell-derived extracellular vesicles (hMSC-EVs), 90 min post-traumatic brain injury (TBI), has been reported to prevent the evolution of acute neuroinflammation into chronic neuroinflammation resulting in the alleviation of long-term cognitive...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239975/ https://www.ncbi.nlm.nih.gov/pubmed/37284464 http://dx.doi.org/10.3389/fnmol.2023.1185883 |
_version_ | 1785053616832249856 |
---|---|
author | Kodali, Maheedhar Madhu, Leelavathi N. Reger, Roxanne L. Milutinovic, Bojana Upadhya, Raghavendra Attaluri, Sahithi Shuai, Bing Shankar, Goutham Shetty, Ashok K. |
author_facet | Kodali, Maheedhar Madhu, Leelavathi N. Reger, Roxanne L. Milutinovic, Bojana Upadhya, Raghavendra Attaluri, Sahithi Shuai, Bing Shankar, Goutham Shetty, Ashok K. |
author_sort | Kodali, Maheedhar |
collection | PubMed |
description | An optimal intranasal (IN) dose of human mesenchymal stem cell-derived extracellular vesicles (hMSC-EVs), 90 min post-traumatic brain injury (TBI), has been reported to prevent the evolution of acute neuroinflammation into chronic neuroinflammation resulting in the alleviation of long-term cognitive and mood impairments. Since hippocampal neurogenesis decline and synapse loss contribute to TBI-induced long-term cognitive and mood dysfunction, this study investigated whether hMSC-EV treatment after TBI can prevent hippocampal neurogenesis decline and synapse loss in the chronic phase of TBI. C57BL6 mice undergoing unilateral controlled cortical impact injury (CCI) received a single IN administration of different doses of EVs or the vehicle at 90 min post-TBI. Quantifying neurogenesis in the subgranular zone-granule cell layer (SGZ-GCL) through 5′-bromodeoxyuridine and neuron-specific nuclear antigen double labeling at ~2 months post-TBI revealed decreased neurogenesis in TBI mice receiving vehicle. However, in TBI mice receiving EVs (12.8 and 25.6 × 10(9) EVs), the extent of neurogenesis was matched to naive control levels. A similar trend of decreased neurogenesis was seen when doublecortin-positive newly generated neurons were quantified in the SGZ-GCL at ~3 months post-TBI. The above doses of EVs treatment after TBI also reduced the loss of pre-and post-synaptic marker proteins in the hippocampus and the somatosensory cortex. Moreover, at 48 h post-treatment, brain-derived neurotrophic factor (BDNF), phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2), and phosphorylated cyclic AMP response-element binding protein (p-CREB) levels were downregulated in TBI mice receiving the vehicle but were closer to naïve control levels in TBI mice receiving above doses of hMSC-EVs. Notably, improved BDNF concentration observed in TBI mice receiving hMSC-EVs in the acute phase was sustained in the chronic phase of TBI. Thus, a single IN dose of hMSC-EVs at 90 min post-TBI can ease TBI-induced declines in the BDNF-ERK-CREB signaling, hippocampal neurogenesis, and synapses. |
format | Online Article Text |
id | pubmed-10239975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102399752023-06-06 A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling Kodali, Maheedhar Madhu, Leelavathi N. Reger, Roxanne L. Milutinovic, Bojana Upadhya, Raghavendra Attaluri, Sahithi Shuai, Bing Shankar, Goutham Shetty, Ashok K. Front Mol Neurosci Molecular Neuroscience An optimal intranasal (IN) dose of human mesenchymal stem cell-derived extracellular vesicles (hMSC-EVs), 90 min post-traumatic brain injury (TBI), has been reported to prevent the evolution of acute neuroinflammation into chronic neuroinflammation resulting in the alleviation of long-term cognitive and mood impairments. Since hippocampal neurogenesis decline and synapse loss contribute to TBI-induced long-term cognitive and mood dysfunction, this study investigated whether hMSC-EV treatment after TBI can prevent hippocampal neurogenesis decline and synapse loss in the chronic phase of TBI. C57BL6 mice undergoing unilateral controlled cortical impact injury (CCI) received a single IN administration of different doses of EVs or the vehicle at 90 min post-TBI. Quantifying neurogenesis in the subgranular zone-granule cell layer (SGZ-GCL) through 5′-bromodeoxyuridine and neuron-specific nuclear antigen double labeling at ~2 months post-TBI revealed decreased neurogenesis in TBI mice receiving vehicle. However, in TBI mice receiving EVs (12.8 and 25.6 × 10(9) EVs), the extent of neurogenesis was matched to naive control levels. A similar trend of decreased neurogenesis was seen when doublecortin-positive newly generated neurons were quantified in the SGZ-GCL at ~3 months post-TBI. The above doses of EVs treatment after TBI also reduced the loss of pre-and post-synaptic marker proteins in the hippocampus and the somatosensory cortex. Moreover, at 48 h post-treatment, brain-derived neurotrophic factor (BDNF), phosphorylated extracellular signal-regulated kinase 1/2 (p-ERK1/2), and phosphorylated cyclic AMP response-element binding protein (p-CREB) levels were downregulated in TBI mice receiving the vehicle but were closer to naïve control levels in TBI mice receiving above doses of hMSC-EVs. Notably, improved BDNF concentration observed in TBI mice receiving hMSC-EVs in the acute phase was sustained in the chronic phase of TBI. Thus, a single IN dose of hMSC-EVs at 90 min post-TBI can ease TBI-induced declines in the BDNF-ERK-CREB signaling, hippocampal neurogenesis, and synapses. Frontiers Media S.A. 2023-05-22 /pmc/articles/PMC10239975/ /pubmed/37284464 http://dx.doi.org/10.3389/fnmol.2023.1185883 Text en Copyright © 2023 Kodali, Madhu, Reger, Milutinovic, Upadhya, Attaluri, Shuai, Shankar and Shetty. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Neuroscience Kodali, Maheedhar Madhu, Leelavathi N. Reger, Roxanne L. Milutinovic, Bojana Upadhya, Raghavendra Attaluri, Sahithi Shuai, Bing Shankar, Goutham Shetty, Ashok K. A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling |
title | A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling |
title_full | A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling |
title_fullStr | A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling |
title_full_unstemmed | A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling |
title_short | A single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and BDNF-ERK-CREB signaling |
title_sort | single intranasal dose of human mesenchymal stem cell-derived extracellular vesicles after traumatic brain injury eases neurogenesis decline, synapse loss, and bdnf-erk-creb signaling |
topic | Molecular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239975/ https://www.ncbi.nlm.nih.gov/pubmed/37284464 http://dx.doi.org/10.3389/fnmol.2023.1185883 |
work_keys_str_mv | AT kodalimaheedhar asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT madhuleelavathin asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT regerroxannel asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT milutinovicbojana asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT upadhyaraghavendra asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT attalurisahithi asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT shuaibing asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT shankargoutham asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT shettyashokk asingleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT kodalimaheedhar singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT madhuleelavathin singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT regerroxannel singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT milutinovicbojana singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT upadhyaraghavendra singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT attalurisahithi singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT shuaibing singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT shankargoutham singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling AT shettyashokk singleintranasaldoseofhumanmesenchymalstemcellderivedextracellularvesiclesaftertraumaticbraininjuryeasesneurogenesisdeclinesynapselossandbdnferkcrebsignaling |